Last reviewed · How we verify
Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol (FAVOR)
Confirm central blood pressure reduction effect of Fimasartan, Valsartan and Atenolol and compare correlation with the measured peripheral (central blood pressure, pulse wave velocity, and flow-mediated dilation) and cerebral blood flow factors (transcranial doppler findings, cerebral blood flow volume) in acute ischemic stroke patients with hypertension.
Details
| Lead sponsor | Ajou University School of Medicine |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 105 |
| Start date | 2012-05 |
| Completion | 2015-09 |
Conditions
- Blood Pressure
- Ischemic Stroke
Interventions
- Fimasartan
- Valsartan
- Atenolol
Primary outcomes
- Central Blood pressure control — 12 weeks